Physician profile
Gene L Syn
NPI 1487842720
$1,507.13
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $11.76 · 2021: $221 · 2022: $225 · 2023: $568 · 2024: $233 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638 · Travel and Lodging: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.16 |
| Travel and Lodging | $272.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $902.77 | 2021-2024 | Axonics |
| Medtronic, INC. | $218.70 | 2024-2025 | Interstim |
| Medtronic USA, INC. | $124.13 | 2019 | |
| Biotissue Holdings INC. | $44.68 | 2024 | |
| Baudax Bio INC. | $42.14 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $38.16 | 2023 | Seglentis |
| Boston Scientific Corporation | $36.32 | 2020-2025 | Axonics |
| Activ Surgical, INC. | $33.77 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $30.20 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.75 | 2022 | |
| Convatec INC. | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Syn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.